CTVA
Corteva, Inc. NYSE Listed May 24, 2019$78.59
+1.58%
vs $77.37
Mkt Cap $52.9B
52w Low $61.00
71.9% of range
52w High $85.46
50d MA $79.71
200d MA $72.77
P/E (TTM)
49.1x
EV/EBITDA
16.3x
P/B
2.2x
Debt/Equity
0.1x
ROE
4.5%
P/FCF
18.8x
RSI (14)
51.70
ATR (14)
$1.74
Beta
0.68
50d MA
$79.71
200d MA
$72.77
Avg Volume
4.1M
Corteva, Inc. operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics. This segment also provides digital solutions that assist farmer decision-making with a view to optimize product selection, and maximize yield and profitability. The Crop Protection segment offers products that protect against weeds, insects and other pests, and diseases, as well as enhances crop health above and below ground through nitrogen management and seed-applied technologies. This segment provides herbicides, insecticides, nitrogen stabilizers, and pasture and range management herbicides. It serves agricultural input industry. The company operates in the United States, Canada, Latin America, the Asia Pacific, Europe, the Middle East, and Africa. Corteva, Inc. was incorporated in 2018 and is headquartered in Indianapolis, Indiana.
9330 Zionsville Road · Indianapolis, IN 46268-0735 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 5, 2026 | AMC | 1.17 | 1.50 | +28.2% | 83.90 | -2.0% | -2.5% | -3.3% | +2.6% | +2.1% | -0.3% | — |
| Feb 3, 2026 | AMC | 0.22 | 0.22 | -1.3% | 75.04 | -2.6% | +0.1% | -3.5% | +0.2% | +1.4% | +0.8% | — |
| Nov 4, 2025 | AMC | -0.51 | -0.23 | +54.6% | 62.50 | +3.5% | +1.9% | -0.8% | +1.6% | +2.2% | +0.2% | — |
| Aug 6, 2025 | AMC | 1.89 | 2.20 | +16.4% | 71.17 | -0.9% | -0.2% | -0.2% | +2.2% | -2.0% | +1.8% | — |
| May 7, 2025 | AMC | 0.87 | 1.13 | +29.3% | 62.48 | +3.4% | +7.0% | +1.4% | +0.3% | -0.1% | -0.5% | — |
| Feb 5, 2025 | AMC | 0.31 | 0.32 | +2.5% | 63.82 | -0.4% | -2.3% | -0.0% | -0.2% | +1.2% | -1.4% | — |
| Nov 6, 2024 | AMC | -0.30 | -0.49 | -61.7% | 61.74 | -6.1% | -5.0% | -0.5% | +0.3% | -2.4% | +0.9% | — |
| Jul 31, 2024 | AMC | 1.73 | 1.83 | +5.8% | 56.10 | -3.8% | -5.5% | -2.7% | -0.5% | -0.3% | -0.8% | — |
| May 1, 2024 | AMC | 0.82 | 0.89 | +8.1% | 53.91 | +5.7% | +5.7% | +0.3% | -1.4% | +2.1% | -1.2% | — |
| Jan 31, 2024 | AMC | 0.06 | 0.15 | +155.5% | 45.48 | +24.2% | +18.9% | -1.9% | -2.3% | +0.6% | +3.8% | — |
| Nov 8, 2023 | AMC | -0.26 | -0.23 | +11.5% | 48.62 | +2.2% | -8.5% | -2.2% | +4.0% | +2.2% | +1.0% | — |
| Aug 3, 2023 | AMC | 1.58 | 1.60 | +1.3% | 55.69 | -1.1% | +0.6% | -2.6% | -0.7% | -1.5% | -2.2% | — |
| May 3, 2023 | AMC | 0.93 | 1.16 | +24.7% | 60.00 | +0.6% | -5.2% | +2.4% | -1.1% | -0.9% | +0.8% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 24 | RBC Capital | Maintains | Outperform → Outperform | — | $79.63 | $79.40 | -0.3% | +0.2% | -0.5% | -0.6% | +0.5% | +2.1% |
| Apr 22 | Oppenheimer | Maintains | Outperform → Outperform | — | $80.35 | $80.66 | +0.4% | -1.2% | +0.4% | +0.2% | -0.5% | -0.6% |
| Apr 21 | Wells Fargo | Maintains | Overweight → Overweight | — | $80.29 | $80.57 | +0.3% | +0.1% | -1.2% | +0.4% | +0.2% | -0.5% |
| Apr 9 | UBS | Maintains | Neutral → Neutral | — | $83.96 | $84.04 | +0.1% | -0.5% | +0.3% | -0.4% | -0.7% | -2.0% |
| Mar 31 | Argus | Maintains | Buy → Buy | — | $82.95 | $83.00 | +0.1% | +0.9% | +0.1% | +2.0% | -1.4% | +1.3% |
| Feb 17 | Mizuho | Maintains | Outperform → Outperform | — | $75.03 | $75.19 | +0.2% | +0.7% | +1.4% | +0.6% | -0.9% | +0.2% |
| Feb 5 | Wells Fargo | Maintains | Overweight → Overweight | — | $75.12 | $74.41 | -0.9% | -3.5% | +0.2% | +1.4% | +0.8% | +1.5% |
| Feb 5 | RBC Capital | Maintains | Outperform → Outperform | — | $75.12 | $74.41 | -0.9% | -3.5% | +0.2% | +1.4% | +0.8% | +1.5% |
| Feb 5 | JP Morgan | Downgrade | Overweight → Neutral | — | $75.12 | $74.41 | -0.9% | -3.5% | +0.2% | +1.4% | +0.8% | +1.5% |
| Feb 5 | Citigroup | Maintains | Neutral → Neutral | — | $75.12 | $74.41 | -0.9% | -3.5% | +0.2% | +1.4% | +0.8% | +1.5% |
| Jan 27 | Oppenheimer | Maintains | Outperform → Outperform | — | $72.63 | $72.61 | -0.0% | +0.5% | +0.1% | +1.1% | -1.4% | +0.5% |
| Jan 21 | Citigroup | Maintains | Neutral → Neutral | — | $68.90 | $70.34 | +2.1% | +3.7% | +0.1% | +0.2% | +1.3% | +0.5% |
| Jan 21 | JP Morgan | Maintains | Overweight → Overweight | — | $68.90 | $70.34 | +2.1% | +3.7% | +0.1% | +0.2% | +1.3% | +0.5% |
| Jan 16 | Mizuho | Maintains | Outperform → Outperform | — | $70.50 | $69.49 | -1.4% | -1.2% | -1.1% | +3.7% | +0.1% | +0.2% |
| Dec 18 | Citigroup | Maintains | Neutral → Neutral | — | $66.43 | $66.83 | +0.6% | +0.8% | -1.0% | +1.2% | +0.1% | +0.3% |
| Nov 11 | Wells Fargo | Maintains | Overweight → Overweight | — | $65.56 | $65.54 | -0.0% | +0.2% | +1.2% | -0.4% | -0.3% | -3.2% |
| Oct 30 | UBS | Maintains | Buy → Buy | — | $63.20 | $61.28 | -3.0% | -2.4% | -0.4% | +1.0% | +0.7% | +1.9% |
| Oct 16 | Wells Fargo | Maintains | Overweight → Overweight | — | $61.91 | $62.00 | +0.1% | -1.5% | +0.7% | +0.9% | -0.0% | +1.9% |
| Oct 13 | Argus | Maintains | Buy → Buy | — | $61.83 | $62.27 | +0.7% | +1.4% | +0.0% | -1.2% | -1.5% | +0.7% |
| Oct 8 | Mizuho | Maintains | Outperform → Outperform | — | $65.61 | $65.18 | -0.7% | -3.8% | -0.6% | -1.5% | +1.4% | +0.0% |
| Oct 6 | UBS | Maintains | Buy → Buy | — | $63.37 | $63.52 | +0.2% | +1.5% | +2.0% | -3.8% | -0.6% | -1.5% |
| Oct 3 | KeyBanc Capital Markets | Downgrade | Overweight → Sector Weight | — | $63.49 | $62.50 | -1.6% | -0.2% | +1.5% | +2.0% | -3.8% | -0.6% |
| Oct 2 | Citigroup | Downgrade | Buy → Neutral | — | $61.47 | $61.33 | -0.2% | +3.3% | -0.2% | +1.5% | +2.0% | -3.8% |
| Oct 2 | JP Morgan | Upgrade | Neutral → Overweight | — | $61.47 | $61.33 | -0.2% | +3.3% | -0.2% | +1.5% | +2.0% | -3.8% |
| Aug 13 | Barclays | Upgrade | Equal Weight → Overweight | — | $71.03 | $72.04 | +1.4% | +1.8% | -0.6% | -0.2% | +0.7% | +0.2% |
| Aug 8 | Wells Fargo | Maintains | Overweight → Overweight | — | $71.05 | $71.30 | +0.4% | -0.2% | +2.2% | -2.0% | +1.8% | -0.6% |
| Aug 8 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $71.05 | $71.30 | +0.4% | -0.2% | +2.2% | -2.0% | +1.8% | -0.6% |
| Aug 7 | UBS | Maintains | Buy → Buy | — | $71.17 | $70.51 | -0.9% | -0.2% | -0.2% | +2.2% | -2.0% | +1.8% |
| Jul 17 | Argus | Maintains | Buy → Buy | — | $72.98 | $73.02 | +0.1% | +0.3% | -0.2% | -0.1% | +1.0% | +0.2% |
| Jul 15 | Oppenheimer | Maintains | Outperform → Outperform | — | $73.11 | $73.37 | +0.4% | -1.4% | +1.2% | +0.3% | -0.2% | -0.1% |
| Jul 14 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $73.57 | $73.78 | +0.3% | -0.6% | -1.4% | +1.2% | +0.3% | -0.2% |
| Jul 10 | RBC Capital | Maintains | Outperform → Outperform | — | $76.20 | $76.07 | -0.2% | -1.8% | -1.7% | -0.6% | -1.4% | +1.2% |
| Jul 9 | UBS | Maintains | Buy → Buy | — | $76.45 | $76.57 | +0.2% | -0.3% | -1.8% | -1.7% | -0.6% | -1.4% |
| Jul 8 | Citigroup | Maintains | Outperform → Outperform | — | $76.58 | $76.90 | +0.4% | -0.2% | -0.3% | -1.8% | -1.7% | -0.6% |
| Jul 8 | BMO Capital | Maintains | Outperform → Outperform | — | $76.58 | $76.90 | +0.4% | -0.2% | -0.3% | -1.8% | -1.7% | -0.6% |
| Jul 7 | Barclays | Maintains | Equal Weight → Equal Weight | — | $77.12 | $77.08 | -0.1% | -0.7% | -0.2% | -0.3% | -1.8% | -1.7% |
| Jun 26 | Citigroup | Maintains | Buy → Buy | — | $73.24 | $73.96 | +1.0% | +1.4% | +0.1% | +0.2% | +0.8% | +2.5% |
| Jun 23 | Wells Fargo | Maintains | Overweight → Overweight | — | $73.72 | $73.79 | +0.1% | +1.0% | -1.5% | -0.1% | +1.4% | +0.1% |
| Jun 6 | Jefferies | Maintains | Buy → Buy | — | $71.20 | $71.42 | +0.3% | +0.6% | +0.5% | -0.6% | +0.7% | +0.6% |
| May 14 | Barclays | Maintains | Equal Weight → Equal Weight | — | $67.90 | $67.43 | -0.7% | -0.5% | +1.0% | +0.5% | +0.3% | +0.5% |
| May 12 | Wells Fargo | Maintains | Overweight → Overweight | — | $67.79 | $69.13 | +2.0% | +0.3% | -0.1% | -0.5% | +1.0% | +0.5% |
| May 9 | Oppenheimer | Maintains | Outperform → Outperform | — | $66.86 | $66.71 | -0.2% | +1.4% | +0.3% | -0.1% | -0.5% | +1.0% |
| May 9 | Morgan Stanley | Maintains | Overweight → Overweight | — | $66.86 | $66.71 | -0.2% | +1.4% | +0.3% | -0.1% | -0.5% | +1.0% |
| May 9 | Citigroup | Maintains | Buy → Buy | — | $66.86 | $66.71 | -0.2% | +1.4% | +0.3% | -0.1% | -0.5% | +1.0% |
| May 9 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $66.86 | $66.71 | -0.2% | +1.4% | +0.3% | -0.1% | -0.5% | +1.0% |
| May 8 | UBS | Maintains | Buy → Buy | — | $62.48 | $64.63 | +3.4% | +7.0% | +1.4% | +0.3% | -0.1% | -0.5% |
| Apr 14 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $59.28 | $59.88 | +1.0% | +1.7% | -1.0% | -0.8% | +0.9% | -1.0% |
| Mar 31 | Argus | Upgrade | Hold → Buy | — | $61.06 | $61.30 | +0.4% | +3.1% | +1.0% | +0.7% | -4.2% | -9.0% |
| Feb 11 | BofA Securities | Maintains | Buy → Buy | — | $62.21 | $62.08 | -0.2% | +1.2% | -1.4% | +1.3% | +1.8% | +0.8% |
| Feb 7 | Oppenheimer | Maintains | Outperform → Outperform | — | $62.36 | $62.50 | +0.2% | -0.0% | -0.2% | +1.2% | -1.4% | +1.3% |
No insider trades available.
8-K · 7.01
! Medium
Unknown — 8-K 7.01: Regulation FD Disclosure
Corteva announced key executive leadership appointments for a planned spinoff structure, signaling management readiness for separation and potential operational independence of two entities.
Apr 14
8-K
Corteva, Inc. -- 8-K Filing
Corteva reported fourth-quarter 2025 results with net sales and continued operating losses, potentially signaling ongoing profitability challenges for the agricultural biotechnology company.
Feb 3
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Vanguard Capital Management Llc | 44,075,854 | $3.7B | New | Mar 2026 |
| 2 | Capital World Investors | 35,998,047 | $3.0B | Added | Mar 2026 |
| 3 | Fmr Llc | 34,971,900 | $2.9B | Added | Mar 2026 |
| 4 | Vanguard Portfolio Management Llc | 30,061,788 | $2.5B | New | Mar 2026 |
| 5 | Franklin Resources Inc | 21,794,607 | $1.8B | Added | Mar 2026 |
| 6 | Aristotle Capital Management, Llc | 20,145,048 | $1.4B | Reduced | Dec 2025 |
| 7 | Morgan Stanley | 17,863,628 | $1.2B | Added | Dec 2025 |
| 8 | Northern Trust Corp | 12,475,876 | $1.0B | Added | Mar 2026 |
| 9 | Invesco Ltd. | 10,862,534 | $909M | Reduced | Mar 2026 |
| 10 | State Farm Mutual Automobile Insurance Co | 7,634,624 | $639M | — | Mar 2026 |
| 11 | Royal Bank Of Canada | 7,458,624 | $624M | Added | Mar 2026 |
| 12 | Janus Henderson Group Plc | 7,254,186 | $607M | New | Mar 2026 |
| 13 | Wells Fargo & Company/mn | 6,147,075 | $515M | New | Mar 2026 |
| 14 | Jpmorgan Chase & Co | 5,646,323 | $468M | Added | Mar 2026 |
| 15 | Bank Of America Corp /de/ | 5,253,039 | $440M | Reduced | Mar 2026 |
| 16 | Bank Of New York Mellon Corp | 4,717,821 | $395M | Added | Mar 2026 |
| 17 | Amundi | 2,900,448 | $243M | New | Mar 2026 |
| 18 | Ubs Group Ag | 2,898,418 | $243M | Added | Mar 2026 |
| 19 | Principal Financial Group Inc | 3,383,744 | $227M | Reduced | Dec 2025 |
| 20 | Aqr Capital Management Llc | 2,536,426 | $211M | Added | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$52.90B
Enterprise Value
$50.06B
P/E (TTM)
49.12x
Forward P/E
21.44x
PEG Ratio
1.80x
P/B
2.17x
P/S
3.04x
P/FCF
18.79x
EV/EBITDA
16.30x
Shares Out
673.2M
Financials (TTM)
Revenue
$17.40B
Net Income
$1.09B
EBITDA
$3.07B
Free Cash Flow
$2.81B
Op Cash Flow
$3.41B
EPS Basic
$1.61
EPS Diluted
$1.60
EPS Forward
$3.67
Gross Margin
43.6%
Op Margin
15.0%
Net Margin
6.3%
Balance Sheet
Total Assets
$42.84B
Total Liab.
$18.46B
Total Equity
$24.39B
Cash
$4.53B
LT Debt
$1.69B
Book Value/Sh
$36.23
Debt/Equity
0.11x
Current Ratio
1.43
Quick Ratio
0.96
Returns & Growth
ROE
4.5%
ROA
2.5%
ROIC
5.9%
Rev Growth YoY
+2.9%
EPS Growth YoY
+22.9%
Price Returns
2W
-6.0%
1M
-3.4%
3M
-2.3%
6M
+16.0%
12M
+10.6%
Technicals
52W High
$85.46
52W Low
$61.00
50d MA
$79.71
200d MA
$72.77
RSI (14)
51.70
ATR (14)
$1.74
Beta
0.68
Avg Volume
4.1M
Dividends
Div Rate
$0.71
Div Yield
0.9%
Frequency
4
Ex-Div Date
Mar 2, 2026
Analyst Price Targets
Consensus
$88.17
High
$95.00
Low
$82.00
Median
$88.00
Data updated apr 25, 2026 3:52am
· Source: financialmodelingprep.com